Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Common Cents Systems and Translational Software Improve Efficiency in Pharmacogenetic Testing

Published: Tuesday, February 04, 2014
Last Updated: Tuesday, February 04, 2014
Bookmark and Share
The collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system.

Common Cents Systems, Inc.(ApolloLIMS) and Translational Software have successfully collaborated to improve Pharmacogenetic (PGx) testing and reporting processes. This strategic collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system to enable their customers to improve turnaround time, decrease errors, and make test results more relevant for clinicians.

There is a rapid adoption of pharmacogenetic testing in laboratories across the nation as clinicians recognize the value of genetic testing. As a result, laboratories are producing large amounts of complex genetic data. To interpret the genetic data into actionable medical information a pharmacogenetic knowledgebase is needed. Typically a clinical laboratory does not have the dedicated resources available to develop a knowledgebase or the IT resources to link the laboratory and knowledgebase together.

The ApolloLIMS Lab Automation component gives the lab automated programmatic processes that intelligently send and receive data directly with the laboratory testing equipment without requiring data entry by the operator.  By combining that with the Apollo eXchange HL7 Interface engine, the companies have been successful in creating a bi-directional seamless integration from the pre-analytic, analytic, and post-analytic phases.  The interface with the Translational Knowledgebase adds the interpretive phase and highly configurable report designs to the integration. Many laboratories have already seen the benefits of this collaboration in terms of elimination of duplicate data entry, streamlined work flow resulting in decreased turnaround time and improved customer satisfaction.

Rob Ringenberg, president of Common Cents Systems, Inc., sees the value that can be delivered to customers through the collaboration.  "Laboratory automation is key to efficiency in the modern laboratory.  ApolloLIMS excels at delivering a high level of automation through instrument interfaces, foreign system interfaces and web products.  By working directly with the senior staff at Translational Software we have been able to greatly reduce the project timeline and deliver a superior end product.”

Until recently, clinical adoption of genomic testing has been inhibited by the massive amounts of data, challenging analysis, and the difficulty of adapting research technologies to the clinical setting. Don Rule, Translational’s founder and CEO, says “we recognized that there was an opportunity to augment current solutions that required knowledge of genetics, pharmacology, and informatics. By combining these skill sets we’ve developed a system that enables diagnostic laboratories to bring pharmacogenetic testing to the market dramatically faster.”
This alliance marries a laboratory's need for intelligent software (like ApolloLIMS) and the extensive pharmacogenetic clinical decision support that Translational Software has to offer. A strategic partnership like this one could not have come at a better time for the laboratory world and the Return on Investment (ROI) by early adopters has already proven it to be successful.




Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Validating the Accuracy of CRISPR-Cas9
IBS Researchers create multiplex Digenome-seq to find errors in CRISPR-Cas9 processes.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!